+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Botulinum Toxin in Medical Cosmetology Market - Global Forecast to 2030- Product Image
Botulinum Toxin in Medical Cosmetology Market - Global Forecast to 2030- Product Image
New

Botulinum Toxin in Medical Cosmetology Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6081098
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Botulinum toxin has transcended its origins as a therapeutic agent for neuromuscular disorders to become a cornerstone of modern medical cosmetology. Advances in formulation, dosing precision, and delivery techniques have broadened its appeal beyond aesthetic enhancement, positioning it as a versatile tool for anti-sweating treatments and a spectrum of neurological indications. The global demographic shift toward minimally invasive procedures, driven by patient preference for reduced downtime and natural-looking outcomes, underscores the catalyst role of botulinum toxin. Practitioners now tailor protocols to address hyperhidrosis in axillary, craniofacial, palmar, and plantar regions, while simultaneously refining approaches to smooth dynamic wrinkles such as crow’s feet, forehead lines, glabellar furrows, marionette creases, and perioral lines.

This dynamic evolution reflects not only technological breakthroughs in molecular engineering but also a growing awareness among consumers and clinicians of its safety profile and therapeutic versatility. As regulatory bodies approve additional indications and formularies diversify, demand continues to climb across multiple age cohorts and end-user settings, from specialized dermatology clinics to luxury medical spas. Such expansion mandates a comprehensive understanding of market drivers, segmentation patterns, and competitive landscapes to inform strategic decision-making and resource allocation.

Transformative Shifts Defining Contemporary Botulinum Toxin Application

The landscape of medical cosmetology is undergoing transformative shifts fueled by innovation, shifting consumer expectations, and evolving regulatory frameworks. Technological advances in toxin purification and stabilization have improved efficacy while reducing immunogenicity, enabling extended durations of clinical effect and more precise dosing regimens. Combined with digital imaging and artificial intelligence-powered analytics, clinicians can now map facial musculature and perspiration zones with unprecedented accuracy, optimizing patient outcomes and driving adoption further.

Parallel to these innovations, regulatory agencies worldwide have streamlined approval pathways for off-label and novel indications, catalyzing research into chronic migraine, spasticity, and cervical dystonia. This cross-pollination of therapeutic insights between neurological and aesthetic applications has accelerated the introduction of hybrid treatment protocols, blending aesthetic rejuvenation with functional improvement. Patient-centric trends, such as demand for same-day procedures and personalized care journeys, have led to the proliferation of mobile health platforms that facilitate virtual consultations, remote follow-ups, and data-driven treatment adjustments.

Moreover, heightened awareness of cosmetic treatments-propelled by social media influencers and educational campaigns-has broadened the end-user base beyond traditional demographics. Together, these shifts underscore a market in flux, where agility, innovation, and regulatory acumen define success.

Assessing the Cumulative Impact of 2025 US Tariffs on Industry Dynamics

In 2025, the U.S. government’s imposition of additional tariffs on pharmaceutical imports introduced new complexities for the botulinum toxin market. Raw materials sourced from overseas biomanufacturers now carry elevated import duties, leading to upward pressure on production costs and, ultimately, treatment prices. Clinics and hospitals have responded by renegotiating supply contracts, exploring domestic manufacturing partnerships, and diversifying procurement channels to mitigate exposure to tariff-induced volatility.

Supply chain recalibrations have also prompted a strategic pivot toward nearshoring and onshore fill-finish operations. Pharmaceutical companies are accelerating investments in U.S.-based bioprocessing facilities to secure uninterrupted access to toxin vials, reduce lead times, and maintain quality standards. At the same time, parallel trade routes have emerged, with distributors sourcing from regions outside traditional European and North American hubs to capitalize on more favorable tariff classifications.

These adjustments have reshaped competitive dynamics: manufacturers with integrated supply chains and agile logistics are leveraging scale efficiencies to sustain pricing competitiveness, while smaller players face margin compression and heightened pressure to demonstrate product differentiation. As the market absorbs these cost shifts, stakeholders must remain vigilant in tracking tariff revisions and aligning procurement strategies accordingly.

Key Segmentation Insights Revealing Diverse Market Drivers and Opportunities

A nuanced segmentation framework reveals critical insights into diverse market vectors. By application, the domain of anti-sweating treatments encompasses axillary, craniofacial, palmar, and plantar hyperhidrosis, each presenting unique injection protocols and patient education imperatives. Facial aesthetics extend to crow’s feet, eye wrinkles, forehead lines, glabellar furrows, marionette lines, and perioral creases, where precision dosing and advanced imaging guide wrinkle modulation. Neurological indications such as cervical dystonia, chronic migraine, and spasticity underscore the toxin’s therapeutic breadth and drive cross-disciplinary collaboration between neurologists and aesthetic practitioners.

Demographically, adults aged 18 to 25 increasingly seek preventative treatments that maintain skin elasticity, while the 26 to 35 cohort prioritizes subtle enhancements to sustain a youthful appearance. Patients between 36 and 45 represent the largest share of cosmetic injections, balancing professional image considerations with anti-aging goals. The 46 to 55 segment embraces both aesthetic and functional applications, often combining treatments to address dynamic lines and muscle-related discomfort. Individuals 56 and above value toxin therapy for both quality-of-life improvements in hyperhidrosis and relief from neuromuscular conditions.

Gender segmentation highlights a predominance of female patients, drawn by social and professional motivations, alongside a growing male client base pursuing anti-sweating interventions and facial contouring. In terms of end-users, beauty clinics and dermatology centers capitalize on their specialized expertise for complex treatments, hospitals integrate toxin therapy into multidisciplinary care pathways, and medical spas leverage experiential environments to attract lifestyle-focused consumers.

Product portfolios bifurcate into botulinum toxin type A variants-abobotulinumtoxinA, incobotulinumtoxinA, onabotulinumtoxinA, and prabotulinumtoxinA-and botulinum toxin type B, represented by rimabotulinumtoxinB. Type A formulations dominate aesthetics and hyperhidrosis segments, while type B maintains a niche in cases of resistance or antibody development. Finally, demand drivers such as the growing popularity of minimally invasive procedures, increased awareness of cosmetic options, rising disposable incomes, and continuous technological advancements collectively underpin sustained market expansion.

Regional Perspectives Highlighting Growth Hotspots and Emerging Markets

Regional dynamics reveal distinct growth trajectories. In the Americas, robust reimbursement frameworks and early adoption of off-label uses drive high per-capita procedure volumes. North America leads in specialist training programs and innovation grants, while Latin American markets exhibit rapid uptake of cost-competitive toxin brands and localized clinical protocols.

Europe, the Middle East, and Africa present a heterogeneous landscape: Western Europe boasts stringent quality and safety regulations that favor established multinational manufacturers, whereas Eastern European countries demonstrate price sensitivity and a preference for biosimilar or novel entrants. The Middle East leverages a high-income consumer base and luxury wellness tourism to fuel demand, and Africa’s emerging economies show potential through growing medical infrastructure investments and awareness campaigns.

Asia-Pacific stands out as the fastest-growing region, driven by expanding middle-class populations in China, India, and Southeast Asia. Cosmetic culture in South Korea and Japan continues to pioneer advanced injection techniques and combination therapies. Regulatory harmonization efforts in ASEAN further facilitate market access, while local partnerships between global toxin suppliers and domestic distributors accelerate product availability.

Competitive Landscape: Profiles of Leading Botulinum Toxin Providers

The competitive landscape features a blend of established pharmaceutical powerhouses and agile biotech innovators. AGMARILUS Bio-Medical Ltd. leverages targeted research partnerships to enhance formulation stability, while Allergan Aesthetics, an AbbVie Company, sustains market leadership through brand equity and a comprehensive product suite. Daewoong Pharmaceutical Co., Ltd. differentiates with unique manufacturing platforms, and Evolus, Inc. competes on pricing and marketing agility to capture value-seeking segments. Hefei Tongyong Pharmaceutical Co., Ltd. and Hugel Pharma focus on regional expansion in Asia-Pacific, establishing local fill-finish capabilities to optimize distribution efficiency.

Ipsen Biopharmaceuticals, Inc. advances toxin science by exploring novel indications, supported by strategic collaborations with academic centers. Lanzhou Institute of Biological Products Co., Ltd. emphasizes biosimilar development to address cost pressures in price-sensitive markets. Medytox Inc. and Merz Pharmaceuticals invest heavily in clinical trials to broaden label claims, while Revance Therapeutics, Inc. pursues innovative peptide-based delivery systems to extend duration of effect. Sihuan Pharmaceutical Holdings Group Ltd. and Young-in Frontier Co., Ltd. round out the roster with niche formulation expertise and agility in navigating regional regulatory landscapes, collectively shaping a vibrant, fragmented market where R&D investment and supply chain resilience determine competitive advantage.

Actionable Recommendations for Industry Leaders Navigating Evolving Market Conditions

Industry leaders must adopt multifaceted strategies to thrive amidst evolving conditions. First, augmenting R&D pipelines through collaborations with academic institutions and specialty research centers will accelerate the development of next-generation formulations and broaden therapeutic indications. Second, diversifying supply chains by investing in regional manufacturing hubs reduces exposure to tariff volatility and logistics disruptions.

Third, fostering clinician education through accredited training programs and digital platforms ensures consistent application standards and maximizes patient safety. Fourth, enhancing patient engagement via telehealth consultations and outcome monitoring tools cultivates loyalty and supports personalized care journeys. Fifth, leveraging data analytics and real-world evidence facilitates targeted marketing campaigns and informs formulary placements. Lastly, exploring mergers, acquisitions, and strategic alliances can secure access to emerging markets, bolster product portfolios, and achieve economies of scale essential for long-term competitiveness.

Conclusion: Synthesizing Trends and Strategic Imperatives in Botulinum Toxin Cosmetology

The convergence of technological innovation, demographic shifts, and regulatory evolution underscores a pivotal moment for botulinum toxin in medical cosmetology. Stakeholders who integrate advanced analytics, prioritize supply chain resilience, and deepen partnerships with clinical communities will capture emerging opportunities. Simultaneously, regions exhibiting rapid adoption-driven by favorable reimbursement policies and rising consumer spending-offer fertile ground for expansion.

Maintaining a balance between global scale and local agility, while sustaining rigorous quality standards, will distinguish market leaders from followers. As patient preferences evolve toward preventive and holistic aesthetic solutions, the ability to tailor offerings across applications, age groups, and treatment settings will be paramount. By synthesizing these trends with strategic foresight, organizations can navigate tariff headwinds, harness segmentation insights, and fortify their position in an increasingly competitive arena.

Market Segmentation & Coverage

This research report categorizes the Botulinum Toxin in Medical Cosmetology Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Anti-Sweating Treatments
    • Axillary Hyperhidrosis
    • Craniofacial Hyperhidrosis
    • Palmar Hyperhidrosis
    • Plantar Hyperhidrosis
  • Facial Aesthetics
    • Crow's Feet
    • Eye Wrinkles
    • Forehead Lines
    • Glabellar Lines
    • Marionette Lines
    • Perioral Lines
  • Neurological Disorders
    • Cervical Dystonia
    • Chronic Migraine
    • Spasticity
  • 18-25 Years
  • 26-35 Years
  • 36-45 Years
  • 46-55 Years
  • 56 Years And Above
  • Female
  • Male
  • Beauty Clinics
  • Dermatology Clinics
  • Hospitals
  • Medical Spas
  • Botulinum Toxin A
    • AbobotulinumtoxinA
    • IncobotulinumtoxinA
    • OnabotulinumtoxinA
    • PrabotulinumtoxinA
  • Botulinum Toxin B
    • RimabotulinumtoxinB
  • Growing Popularity Of Minimally Invasive Procedures
  • Increased Awareness Of Cosmetic Treatments
  • Rising Disposable Income
  • Technological Advancements

This research report categorizes the Botulinum Toxin in Medical Cosmetology Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Botulinum Toxin in Medical Cosmetology Market to delves into recent significant developments and analyze trends in each of the following companies:

  • AGMARILUS Bio-Medical Ltd.
  • Allergan Aesthetics, an AbbVie Company
  • Daewoong Pharmaceutical Co., Ltd.
  • Evolus, Inc.
  • Hefei Tongyong Pharmaceutical Co., Ltd.
  • Hugel Pharma
  • Ipsen Biopharmaceuticals, Inc.
  • Lanzhou Institute of Biological Products Co., Ltd.
  • Medytox Inc.
  • Merz Pharmaceuticals
  • Revance Therapeutics, Inc.
  • Sihuan Pharmaceutical Holdings Group Ltd.
  • Young-in Frontier Co., Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Botulinum Toxin in Medical Cosmetology Market, by Application
8.1. Introduction
8.2. Anti-Sweating Treatments
8.2.1. Axillary Hyperhidrosis
8.2.2. Craniofacial Hyperhidrosis
8.2.3. Palmar Hyperhidrosis
8.2.4. Plantar Hyperhidrosis
8.3. Facial Aesthetics
8.3.1. Crow's Feet
8.3.2. Eye Wrinkles
8.3.3. Forehead Lines
8.3.4. Glabellar Lines
8.3.5. Marionette Lines
8.3.6. Perioral Lines
8.4. Neurological Disorders
8.4.1. Cervical Dystonia
8.4.2. Chronic Migraine
8.4.3. Spasticity
9. Botulinum Toxin in Medical Cosmetology Market, by Age Group
9.1. Introduction
9.2. 18-25 Years
9.3. 26-35 Years
9.4. 36-45 Years
9.5. 46-55 Years
9.6. 56 Years And Above
10. Botulinum Toxin in Medical Cosmetology Market, by Gender
10.1. Introduction
10.2. Female
10.3. Male
11. Botulinum Toxin in Medical Cosmetology Market, by End-User
11.1. Introduction
11.2. Beauty Clinics
11.3. Dermatology Clinics
11.4. Hospitals
11.5. Medical Spas
12. Botulinum Toxin in Medical Cosmetology Market, by Product Type
12.1. Introduction
12.2. Botulinum Toxin A
12.2.1. AbobotulinumtoxinA
12.2.2. IncobotulinumtoxinA
12.2.3. OnabotulinumtoxinA
12.2.4. PrabotulinumtoxinA
12.3. Botulinum Toxin B
12.3.1. RimabotulinumtoxinB
13. Botulinum Toxin in Medical Cosmetology Market, by Demand Driver
13.1. Introduction
13.2. Growing Popularity Of Minimally Invasive Procedures
13.3. Increased Awareness Of Cosmetic Treatments
13.4. Rising Disposable Income
13.5. Technological Advancements
14. Americas Botulinum Toxin in Medical Cosmetology Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Botulinum Toxin in Medical Cosmetology Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Botulinum Toxin in Medical Cosmetology Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AGMARILUS Bio-Medical Ltd.
17.3.2. Allergan Aesthetics, an AbbVie Company
17.3.3. Daewoong Pharmaceutical Co., Ltd.
17.3.4. Evolus, Inc.
17.3.5. Hefei Tongyong Pharmaceutical Co., Ltd.
17.3.6. Hugel Pharma
17.3.7. Ipsen Biopharmaceuticals, Inc.
17.3.8. Lanzhou Institute of Biological Products Co., Ltd.
17.3.9. Medytox Inc.
17.3.10. Merz Pharmaceuticals
17.3.11. Revance Therapeutics, Inc.
17.3.12. Sihuan Pharmaceutical Holdings Group Ltd.
17.3.13. Young-in Frontier Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET MULTI-CURRENCY
FIGURE 2. BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AXILLARY HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY CRANIOFACIAL HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PALMAR HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PLANTAR HYPERHIDROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY CROW'S FEET, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY EYE WRINKLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FOREHEAD LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GLABELLAR LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY MARIONETTE LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PERIORAL LINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY CERVICAL DYSTONIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY CHRONIC MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY SPASTICITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY 18-25 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY 26-35 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY 36-45 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY 46-55 YEARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY 56 YEARS AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BEAUTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY MEDICAL SPAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ABOBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY INCOBOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ONABOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRABOTULINUMTOXINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY RIMABOTULINUMTOXINB, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GROWING POPULARITY OF MINIMALLY INVASIVE PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY INCREASED AWARENESS OF COSMETIC TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY RISING DISPOSABLE INCOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY TECHNOLOGICAL ADVANCEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 89. CANADA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. CANADA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 91. CANADA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 92. CANADA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 93. CANADA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 94. CANADA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 95. CANADA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. CANADA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. CANADA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 98. CANADA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 99. CANADA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 105. MEXICO BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 106. MEXICO BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. MEXICO BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 109. MEXICO BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 110. MEXICO BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 126. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. AUSTRALIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. AUSTRALIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 137. AUSTRALIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 138. AUSTRALIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 139. AUSTRALIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 140. AUSTRALIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 141. AUSTRALIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. AUSTRALIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 146. CHINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. CHINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 148. CHINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 149. CHINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 150. CHINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 151. CHINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 152. CHINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. CHINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. CHINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 155. CHINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 156. CHINA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 157. INDIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. INDIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 159. INDIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 160. INDIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 161. INDIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 162. INDIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 163. INDIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. INDIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 165. INDIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 166. INDIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 167. INDIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 168. INDONESIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. INDONESIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 170. INDONESIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 171. INDONESIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 172. INDONESIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 173. INDONESIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 174. INDONESIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. INDONESIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 176. INDONESIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 177. INDONESIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 178. INDONESIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 179. JAPAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. JAPAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 181. JAPAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 182. JAPAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 183. JAPAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 184. JAPAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 185. JAPAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. JAPAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. JAPAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 188. JAPAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 189. JAPAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 190. MALAYSIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. MALAYSIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 192. MALAYSIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 193. MALAYSIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 194. MALAYSIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 195. MALAYSIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 196. MALAYSIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. MALAYSIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. MALAYSIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 199. MALAYSIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 200. MALAYSIA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 201. PHILIPPINES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. PHILIPPINES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 203. PHILIPPINES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 204. PHILIPPINES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 205. PHILIPPINES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 206. PHILIPPINES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 207. PHILIPPINES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 208. PHILIPPINES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 212. SINGAPORE BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. SINGAPORE BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 214. SINGAPORE BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 215. SINGAPORE BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 216. SINGAPORE BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 217. SINGAPORE BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 218. SINGAPORE BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 227. SOUTH KOREA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 228. SOUTH KOREA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 229. SOUTH KOREA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. SOUTH KOREA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. SOUTH KOREA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 237. TAIWAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 238. TAIWAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 239. TAIWAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 240. TAIWAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. TAIWAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. TAIWAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 243. TAIWAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 244. TAIWAN BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 245. THAILAND BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. THAILAND BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 247. THAILAND BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 248. THAILAND BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 249. THAILAND BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 250. THAILAND BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 251. THAILAND BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. THAILAND BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. THAILAND BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 254. THAILAND BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 255. THAILAND BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 256. VIETNAM BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. VIETNAM BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 258. VIETNAM BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 260. VIETNAM BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 261. VIETNAM BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 262. VIETNAM BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. VIETNAM BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. VIETNAM BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 265. VIETNAM BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 266. VIETNAM BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY FACIAL AESTHETICS, 2018-2030 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, 2018-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN A, 2018-2030 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY BOTULINUM TOXIN B, 2018-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY DEMAND DRIVER, 2018-2030 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 279. DENMARK BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. DENMARK BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZE, BY ANTI-SWEATING TREATMENTS, 2018-2030 (USD MILLION)
TABLE 281. DENMARK BOTULINUM TOXIN IN MEDICAL COSMETOLOGY MARKET SIZ

Companies Mentioned

  • AGMARILUS Bio-Medical Ltd.
  • Allergan Aesthetics, an AbbVie Company
  • Daewoong Pharmaceutical Co., Ltd.
  • Evolus, Inc.
  • Hefei Tongyong Pharmaceutical Co., Ltd.
  • Hugel Pharma
  • Ipsen Biopharmaceuticals, Inc.
  • Lanzhou Institute of Biological Products Co., Ltd.
  • Medytox Inc.
  • Merz Pharmaceuticals
  • Revance Therapeutics, Inc.
  • Sihuan Pharmaceutical Holdings Group Ltd.
  • Young-in Frontier Co., Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Botulinum Toxins in Dermatology & Cosmetology Market - Global Forecast to 2030 - Product Image

Botulinum Toxins in Dermatology & Cosmetology Market - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global, United States Global, United States
From
Injectable Botulinum Toxin Type A Market by Age Group (25-50 Years, Above 50 Years, Below 25 Years), Distribution Channel (Offline Retail, Online Retail), End-User, Application - Global Forecast 2025-2030 - Product Image

Injectable Botulinum Toxin Type A Market by Age Group (25-50 Years, Above 50 Years, Below 25 Years), Distribution Channel (Offline Retail, Online Retail), End-User, Application - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Botulinum Toxin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Image

Botulinum Toxin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • 99 Pages
  • Global
From
North America Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product, Application, and End User - Product Image

North America Botulinum Toxin Market Forecast to 2031 - Regional Analysis - by Product, Application, and End User

  • Report
  • 77 Pages
  • North America
From
Botulinum Toxin Market Report 2025 - Product Image

Botulinum Toxin Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.